351 related articles for article (PubMed ID: 31399954)
1. Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.
Verma AK; Khan E; Bhagwat SR; Kumar A
Mol Neurobiol; 2020 Jan; 57(1):566-584. PubMed ID: 31399954
[TBL] [Abstract][Full Text] [Related]
2. Triplet repeats in transcripts: structural insights into RNA toxicity.
Galka-Marciniak P; Urbanek MO; Krzyzosiak WJ
Biol Chem; 2012 Nov; 393(11):1299-315. PubMed ID: 23052488
[TBL] [Abstract][Full Text] [Related]
3. The Interaction of DNA-Binding Ligands with Trinucleotide-Repeat DNA: Implications for Therapy and Diagnosis of Neurological Disorders.
Chang CK; Jhan CR; Hou MH
Curr Top Med Chem; 2015; 15(14):1398-408. PubMed ID: 25866276
[TBL] [Abstract][Full Text] [Related]
4. Targeting Expanded Repeats by Small Molecules in Repeat Expansion Disorders.
Nakamori M; Mochizuki H
Mov Disord; 2021 Feb; 36(2):298-305. PubMed ID: 33284473
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics studies of trinucleotide repeat DNA involved in neurodegenerative disorders.
Jithesh PV; Singh P; Joshi R
J Biomol Struct Dyn; 2001 Dec; 19(3):479-95. PubMed ID: 11790146
[TBL] [Abstract][Full Text] [Related]
6. RNA structure of trinucleotide repeats associated with human neurological diseases.
Sobczak K; de Mezer M; Michlewski G; Krol J; Krzyzosiak WJ
Nucleic Acids Res; 2003 Oct; 31(19):5469-82. PubMed ID: 14500809
[TBL] [Abstract][Full Text] [Related]
7. Possibilities and challenges of small molecule organic compounds for the treatment of repeat diseases.
Nakatani K
Proc Jpn Acad Ser B Phys Biol Sci; 2022; 98(1):30-48. PubMed ID: 35013029
[TBL] [Abstract][Full Text] [Related]
8. Molecular conformations and dynamics of nucleotide repeats associated with neurodegenerative diseases: double helices and CAG hairpin loops.
Pan F; Zhang Y; Xu P; Man VH; Roland C; Weninger K; Sagui C
Comput Struct Biotechnol J; 2021; 19():2819-2832. PubMed ID: 34093995
[TBL] [Abstract][Full Text] [Related]
9. The role of the immune system in triplet repeat expansion diseases.
Olejniczak M; Urbanek MO; Krzyzosiak WJ
Mediators Inflamm; 2015; 2015():873860. PubMed ID: 25873774
[TBL] [Abstract][Full Text] [Related]
10. A Ligand That Targets CUG Trinucleotide Repeats.
Li J; Matsumoto J; Bai LP; Murata A; Dohno C; Nakatani K
Chemistry; 2016 Oct; 22(42):14881-14889. PubMed ID: 27573860
[TBL] [Abstract][Full Text] [Related]
11. Small non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases.
Martí E; Estivill X
Front Mol Neurosci; 2013 Dec; 6():45. PubMed ID: 24348326
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in CAG trinucleotide repeat expansion disorders: an integrated review of the literature.
Dumitrescu L; Popescu BO
CNS Neurol Disord Drug Targets; 2015; 14(2):176-93. PubMed ID: 25613508
[TBL] [Abstract][Full Text] [Related]
13. Trinucleotide repeats associated with human disease.
Mitas M
Nucleic Acids Res; 1997 Jun; 25(12):2245-54. PubMed ID: 9171073
[TBL] [Abstract][Full Text] [Related]
14. Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target.
Krzyzosiak WJ; Sobczak K; Wojciechowska M; Fiszer A; Mykowska A; Kozlowski P
Nucleic Acids Res; 2012 Jan; 40(1):11-26. PubMed ID: 21908410
[TBL] [Abstract][Full Text] [Related]
15. Roles of trinucleotide-repeat RNA in neurological disease and degeneration.
Li LB; Bonini NM
Trends Neurosci; 2010 Jun; 33(6):292-8. PubMed ID: 20398949
[TBL] [Abstract][Full Text] [Related]
16. DNA trinucleotide repeat expansion in neuropsychiatric patients.
Mohmood S; Sherwani A; Khan F; Khan RH; Azfer A
Med Sci Monit; 2003 Sep; 9(9):RA237-45. PubMed ID: 12960939
[TBL] [Abstract][Full Text] [Related]
17. Disease-associated repeat instability and mismatch repair.
Schmidt MHM; Pearson CE
DNA Repair (Amst); 2016 Feb; 38():117-126. PubMed ID: 26774442
[TBL] [Abstract][Full Text] [Related]
18. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
[TBL] [Abstract][Full Text] [Related]
19. No evidence of expansion of CAG or GAA repeats in schizophrenia families and monozygotic twins.
Vincent JB; Kalsi G; Klempan T; Tatuch Y; Sherrington RP; Breschel T; McInnis MG; Brynjolfsson J; Petursson H; Gurling HM; Gottesman II; Torrey EF; Petronis A; Kennedy JL
Hum Genet; 1998 Jul; 103(1):41-7. PubMed ID: 9737774
[TBL] [Abstract][Full Text] [Related]
20. Expanded CAG/CTG repeats resist gene silencing mediated by targeted epigenome editing.
Yang B; Borgeaud AC; Buřičová M; Aeschbach L; Rodríguez-Lima O; Ruiz Buendía GA; Cinesi C; Taylor AS; Baubec T; Dion V
Hum Mol Genet; 2022 Feb; 31(3):386-398. PubMed ID: 34494094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
